Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model

[11] Geisler S(2008)Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium Cell Death Differ 15 1641-412

[12] Johnsen H(2010)Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis J Natl Cancer Inst 102 1398-93

[13] Bertucci F(2010)Eicosanoids and cancer Nat Rev Cancer 10 181-86

[14] Finetti P(2009)The COX-2/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 377-20

[15] Cervera N(2011)COX-2 and PGE2-dependent immunomodulation in breast cancer Prostaglandins Other Lipid Mediat 96 14-74

[16] Esterni B(2003)Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells Exp Cell Res 289 265-6

[17] Hermitte F(2004)Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proc Natl Acad Sci U S A 101 591-82

[18] Viens P(2009)Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models Mol Oncol 3 469-35

[19] Nakanishi M(2014)Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo J Med Chem 57 7523-107

[20] Rosenberg DW(2012)In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts J Magn Reson Imaging 35 1098-12

[11] Geisler S(2008)Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium Cell Death Differ 15 1641-412

[12] Johnsen H(2010)Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis J Natl Cancer Inst 102 1398-93

[13] Bertucci F(2010)Eicosanoids and cancer Nat Rev Cancer 10 181-86

[14] Finetti P(2009)The COX-2/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 377-20

[15] Cervera N(2011)COX-2 and PGE2-dependent immunomodulation in breast cancer Prostaglandins Other Lipid Mediat 96 14-74

[16] Esterni B(2003)Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells Exp Cell Res 289 265-6

[17] Hermitte F(2004)Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proc Natl Acad Sci U S A 101 591-82

[18] Viens P(2009)Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models Mol Oncol 3 469-35

[19] Nakanishi M(2014)Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo J Med Chem 57 7523-107

[20] Rosenberg DW(2012)In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts J Magn Reson Imaging 35 1098-12